ArticleCancer cell2019

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.

Xiaohong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.